Clinical Trial Update: Efficacy and Safety of Minocycline in Patients With Moderate to Severe Acute Ischemic Stroke [Phase 3]

View source ↗

Summary

A completed Phase 3 clinical trial evaluated the efficacy and safety of minocycline in patients with moderate to severe acute ischemic stroke.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• Minocycline (minocycline)

Snippet

Sponsor: Beijing Tiantan Hospital | Conditions: Ischemic Stroke, Acute | Phase 3 | Status: COMPLETED